Authors: Xin Wang Zhifei Wang Yanming Xie Wen Zhang Xing Liao Yanpeng Chang Specialty Committee of Evaluation of Postmarketing Chinese Medicines of World Federation of Chinese Medicine Societies
Publish Date: 2014/03/27
Volume: 21, Issue: 6, Pages: 473-480
Abstract
Pharmacoeconomics is an important part of the postmarketing Chinese medicine CM evaluation and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair Every country’s guidelines for pharmacoeconomic evaluation act as reference guidelines we have already drawn up the guideline that takes into account the special characteristics of CM and these are in preparation for the postmarketing CM pharmacoeconomic evaluationSupported by the Research on Key Techniques of Reevaluation of Postmarketing Chinese Medicines the Ministry of Science and Technology No 2009ZX09502030 the SeventhScience Foundation of China Academy of Chinese Medical Sciences No ZZ070817 and National Natural Science Foundation of China General program No 81202776
Keywords: